Other pharmaceutical — Revenue
Zoetis Other pharmaceutical — Revenue decreased by 16.0% to $158.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $159.00M to $158.00M. Over 4 years (FY 2021 to FY 2025), Other pharmaceutical — Revenue shows a downward trend with a -7.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful diversification or growth in specialized therapeutic markets, while a decrease may indicate declining demand for niche products or a strategic shift in product focus.
Detailed definition
This metric represents the total revenue generated from the sale of pharmaceutical products that fall outside of the com...
Peer comparison
Peers in the animal health and pharmaceutical sectors often report similar 'other' or 'specialty' segments, though the specific product composition varies significantly based on the company's R&D focus and acquisition history.
zts_segment_other_pharmaceutical_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $248.00M | $243.00M | $249.00M | $254.00M | $265.00M | $252.00M | $272.00M | $294.00M | $315.00M | $313.00M | $358.00M | $156.00M | $153.00M | $169.00M | $180.00M | $159.00M | $172.00M | $178.00M | $188.00M | $158.00M |
| QoQ Change | — | -2.0% | +2.5% | +2.0% | +4.3% | -4.9% | +7.9% | +8.1% | +7.1% | -0.6% | +14.4% | -56.4% | -1.9% | +10.5% | +6.5% | -11.7% | +8.2% | +3.5% | +5.6% | -16.0% |
| YoY Change | — | — | — | — | +6.9% | +3.7% | +9.2% | +15.7% | +18.9% | +24.2% | +31.6% | -46.9% | -51.4% | -46.0% | -49.7% | +1.9% | +12.4% | +5.3% | +4.4% | -0.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zoetis's other pharmaceutical — revenue?
- Zoetis (ZTS) reported other pharmaceutical — revenue of $158.00M in Q1 2026.
- How has Zoetis's other pharmaceutical — revenue changed year-over-year?
- Zoetis's other pharmaceutical — revenue decreased by 0.6% year-over-year, from $159.00M to $158.00M.
- What is the long-term trend for Zoetis's other pharmaceutical — revenue?
- Over 4 years (2021 to 2025), Zoetis's other pharmaceutical — revenue has grown at a -7.8% compound annual growth rate (CAGR), from $966.00M to $697.00M.
- What does other pharmaceutical — revenue mean?
- Revenue generated from specialized or niche animal health pharmaceutical products outside of the company's main product lines.